Dispersible Formulation of Amoxicillin in the Treatment of Non-Severe Community-Acquired Pneumonia in Children
The paper presents the data on the etiology of non-severe forms of community-acquired pneumonia in children and choosing adequate antibiotic initial treatment with dispersing dosage form of amoxicillin.
Main Authors: | Ye.I. Yulish, I.V. Balychevtseva, S.G. Gadetskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2013-03-01
|
Series: | Zdorovʹe Rebenka |
Subjects: | |
Online Access: | http://childshealth.zaslavsky.com.ua/article/view/88230 |
Similar Items
-
Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi
by: Amy Sarah Ginsburg, et al.
Published: (2021-06-01) -
Amoxicillin, the Main Drug for Treating Community-Acquired Pneumonia and Otitis Media, Recommended but Often Not Followed
by: M. D. Bakradze, et al.
Published: (2016-12-01) -
AMOXYCILLIN FOR COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
by: A. B. MALAKHOV, et al.
Published: (2017-07-01) -
COMMUNITY AQUIRED PNEUMONIA IN ADULTS: POSSIBILITIES OF TREATMENT IN OUTPATIENT CONDITIONS
by: I. V. Leschenko
Published: (2017-11-01) -
Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)